10Grunewald K, Haun M, Urbanek M, et al. Mammaglobi gene expression., asuperior marker of breast cancer cells in peripheral blood in comparison toepidermal-growth-facto receptor and cytokeratin-19[J]. Lab Invest,2000,80(7):1071-1077.
5Canizares F, Sola J, Perez M, et al. Preoperative values of CAI5- 3 as prognostive factors in primary breast cancer[J]. Br J Cancer, 2002, 86(8) : 1217.
6Molina R, Filella X, A licarte J, et al. Prospective evaluation of CEA and CA15- 3 in partients with locoregional breast cancer[J]. Anticaneer Res, 2003, 23(2A). 1035.
7万德森.临床肿瘤学[M].第2版.北京:科学出版社,2008:300.
8Begic A, Kucukalic - Selimovic E, Obralic N, et al. Correla- tion between bone scintigraphy and tumor markers in patients with breast carcinoma [ J ]. Bosn J Basic Med Sci, 2006, 6 (1): 75.
9Iwase H, Kobayashi S, Itoh Y, et al. Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer[J]. Breast Cancer Res Treat, 1995, 33(1) : 83.
10Arslan N, Serdar M, Deveci S, et al. Use of CAI5 3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial di- agnosis[J]. Ann Nucl Med, 2000, 14(5) : 395.
